Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)
Clinical trial NCT07246889 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07246889
- Sponsor
- Ausper Biopharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-12
- Primary completion
- 2026-12-18
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.